Barrett & Company, Inc. Anika Therapeutics, Inc. Transaction History
Barrett & Company, Inc.
- $211 Billion
- Q1 2024
A detailed history of Barrett & Company, Inc. transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Barrett & Company, Inc. holds 260 shares of ANIK stock, worth $6,767. This represents 0.0% of its overall portfolio holdings.
Number of Shares
260
Previous 260
-0.0%
Holding current value
$6,767
Previous $5.89 Million
12.08%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ANIK
# of Institutions
119Shares Held
11.9MCall Options Held
5.9KPut Options Held
6.3K-
Trigran Investments, Inc.2.07MShares$53.9 Million5.1% of portfolio
-
Black Rock Inc. New York, NY1.56MShares$40.6 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX810KShares$21.1 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA774KShares$20.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY702KShares$18.3 Million0.0% of portfolio
About Anika Therapeutics, Inc.
- Ticker ANIK
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,599,900
- Market Cap $380M
- Description
- Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...